"Dynamite:" Human stem cells restore hearing in gerbil study
This Associated Press article, featured in USA Today on Sept. 13, quotes Dr. Yehoash Raphael, one of the original Taubman Scholars at the Taubman Instittue.
By Malcolm Ritter, Associated Press
NEW YORK -- For the first time, scientists have improved hearing in deaf animals by using human embryonic stem cells, an encouraging step for someday treating people with certain hearing disorders.
"It's a dynamite study (and) a significant leap forward," said one expert familiar with the work, Dr. Lawrence Lustig of the University of California, San Francisco.
The experiment involved an uncommon form of deafness, one that affects fewer than 1% to perhaps 15% of hearing-impaired people. And the treatment wouldn't necessarily apply to all cases of that disorder. Scientists hope the approach can be expanded to help with more common forms of deafness. But in any case, it will be years before human patients might benefit.
Results of the work, done in gerbils, were reported online Wednesday in the journal Nature by a team led by Dr. Marcelo Rivolta of the University of Sheffield in England.
Click here to read the entire article.
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
- June 14, 2013
- June 05, 2013
- May 31, 2013
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.